Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Closing the Loop In Critical Care

Objetivo

Dysglycaemia affects 75% of critical care patients and increases 30-day mortality up to fivefold. Glucose clamping at normoglycaemia reduces mortality by 29%, serious infections by 53%, and major cardiovascular events by 43%, but has never entered clinical practice because no reliable real-time intravascular glucose sensor has existed. GlucoClamp is the first automated closed-loop glucose control system designed for critical care: an intravascular optical sensor placed through an existing arterial catheter feeds real-time glucose values into a software controller that adjusts IV glucose infusion automatically, while insulin remains under nurse control.

CLICC is a 22-month project advancing GlucoClamp from TRL 6 to TRL 8 with five objectives: (1) transfer sensor manufacturing to a qualified contract manufacturer and validate a scalable production process; (2) finalise and freeze IEC 62304-compliant GlucoClamp software; (3) complete MDR-compliant validation including a first-in-human closed-loop clinical investigation in 30 cardiac and abdominal surgery patients; (4) compile the full MDR Annex II/III technical file for CE-mark submission; and (5) protect foreground IP via 3 PCT applications, confirm FDA 510(k) and PMDA regulatory pathways, and secure a signed commercial agreement with the identified pilot customer.

An EIC grant of EUR 2.5M de-risks the EUR 19M private investment needed for subsequent market entry across EU, US and Japan, directly serving the EIC Work Programme priority for breakthrough medical technologies with proven clinical benefit and scalable commercial impact.

Ámbito científico (EuroSciVoc)

Este proyecto aún no se ha clasificado con EuroSciVoc.
Sugiera los ámbitos científicos que considere más relevantes y ayúdenos a mejorar nuestro servicio de clasificación.

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-EIC-ACC - HORIZON EIC Accelerator

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) HORIZON-EIC-2026-ACCELERATOR-02

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

GLUCOSET AS
Aportación neta de la UEn
€ 2 499 998,07
Dirección
SLUPPENVEGEN 6
7037 Oslo
Noruega
Pyme
Sí
Región
Norge Trøndelag Trøndelag
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
Sin datos